Hormone Health · Clinical Protocol
Retatrutide for Men 45–55
Male Patient · Metabolic Optimization · 12-Week Protocol · Standard & Accelerated Tracks
Concentration: 4 mg/mL · Route: Subcutaneous · Once Weekly
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist — the next generation of metabolic peptide therapy. This protocol for men aged 45–55 starts conservatively and offers two titration tracks based on individual tolerance and weight loss response.
Instant digital download · Clinical reference document
Why Retatrutide Is Different
Triple Receptor. Triple Impact.
Unlike semaglutide (single pathway) or tirzepatide (dual pathway), retatrutide activates three receptors simultaneously — amplifying fat oxidation, energy expenditure, and metabolic flexibility in ways no prior GLP-1 generation could achieve.
The Protocol
Four Phases. Twelve Weeks.
Foundation Phase
Conservative start at 4 mg/mL to establish baseline tolerance. Both tracks begin identically. Assess GI response, energy changes, and appetite suppression.
Titration Phase
Tracks diverge here. Standard track advances cautiously (+5 units weekly). Accelerated track is available only for patients tolerating well with moderate weight loss — not for rapid responders or those with GI symptoms.
Optimization Phase
Full metabolic activation. Triple-receptor synergy produces measurable body composition shifts. Monitor glucose, energy, and sleep quality closely.
Maintenance & Assessment
Consolidate results. Labs assessment recommended. Plan for cycling, dose reduction, or continuation based on goals and tolerance profile.
Get the Protocol
Instant Digital Access
Retatrutide Male Protocol™
Instant digital download · Yours forever
- 12-Week Titration Protocol (PDF/DOCX)
- Standard Track Dosing Schedule
- Accelerated Track Dosing Schedule
- Concentration Guide at 4 mg/mL
- Triple Receptor Mechanism Overview
- Side Effect Management & Safety Notes
- Injection Site Rotation Guide
- Monitoring & Labs Recommendation Checklist
- Lifestyle & Nutrition Amplifiers
- Lifetime access + all future updates
🔒 Secure checkout via Stripe · Instant delivery
This protocol is intended for use under clinical supervision. Retatrutide is a prescription medication in clinical development — all dosing decisions must be individualized by a licensed provider based on patient history and labs. This document is a clinical reference tool, not a substitute for medical advice.
